FDA Inspection
AdhexpharmaAdhexpharma – FDA Inspection, Jun 14, 2023
Record Details
This FDA Inspection record concerns Adhexpharma, with an inspection on June 14, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Adhexpharma
- Inspection Date
- June 14, 2023
- Product Type
- Drugs
View Company Profile
ID · 64d984a5-5e0e-48f9-b927-137b8df0e19c
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1270959
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Adhexpharma
2| Date | Classification | Office | Project area |
|---|---|---|---|
| July 19, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 3, 2017 | NAI | Center for Devices and Radiological Health | Compliance: Devices |
Other documents for Adhexpharma
- FDA Inspection 1133602 - 2019-07-19
- FDA Inspection 1008978 - 2017-02-03
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.